TrialPloS one2013

Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.

Nirianne Marie Q Palacpac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.